INDOUS vs UNITEDTEA: Stock Comparison

INDO US BIOTECH vs UNITED NILGIRI TEAUpdated 15 Sept 26, 2:59 PM ISTNSE & company filings

UNITED NILGIRI TEA is the larger company by market capitalisation. INDO US BIOTECH shows a higher ROE and a higher ROCE, while UNITED NILGIRI TEA shows faster revenue growth, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

INDOUS leads 3; UNITEDTEA leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

INDOUSUNITEDTEA

Valuation lens

What price are you paying?

Market CapContext only
₹160 Cr
₹211 Cr
P/E RatioSame reading
0x
0x
P/B RatioSame reading
0x
0x
EPSUNITEDTEA has the higher reading
₹1.51
₹12.76
Book ValueContext only
₹46.15
₹482.91
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
UNITEDTEA is the larger company
₹211 Cr vs ₹160 Cr
EPS
UNITEDTEA has higher earnings per share
₹12.76 vs ₹1.51
Revenue Growth (TTM YoY)
UNITEDTEA has faster revenue growth
-13.8% vs -22%
EPS Growth (TTM YoY)
UNITEDTEA has faster EPS growth
-4.3% vs -47.3%
Qtr Sales Growth
INDOUS has stronger quarterly sales growth
26.75% vs 21.56%
Qtr Profit Growth
UNITEDTEA has stronger quarterly profit growth
74.03% vs 54.05%
ROE
INDOUS has a higher ROE
14.18% vs 9.09%
ROCE
INDOUS has a higher ROCE
12.34% vs 9.37%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDOUSUNITEDTEA
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryOther Agricultural ProductsTea & Coffee

Price

MetricINDOUSUNITEDTEA
Live Price₹78.29₹425
Day Change0.06%-1.84%
Volume2,0956,119
52-Week High₹159₹590
52-Week Low₹70₹412
Distance from 52W High-50.76%-27.97%

Valuation

MetricINDOUSUNITEDTEA
Market Cap₹160 Cr₹211 Cr
P/E Ratio0x0x
P/B Ratio0x0x
EPS₹1.51₹12.76
Book Value₹46.15₹482.91
Dividend Yield0%0%

Growth

MetricINDOUSUNITEDTEA
Revenue Growth (TTM YoY)-22%-13.8%
EPS Growth (TTM YoY)-47.3%-4.3%
Qtr Sales Growth26.75%21.56%
Qtr Profit Growth54.05%74.03%

Profitability & Leverage

MetricINDOUSUNITEDTEA
ROE14.18%9.09%
ROCE12.34%9.37%
Net Margin11.88%26.33%
Operating Margin14.64%31.25%
Debt to Equity0.4x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricINDOUSUNITEDTEA
Promoter Holding68.29%49.86%
FII Holding0.01% 0.17 pp0%
DII Holding3.58% 0.34 pp
Public Holding31.7% 0.17 pp46.56% 0.35 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDO US BIOTECH and UNITED NILGIRI TEA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.